• Skip to primary navigation
  • Skip to main content
  • Skip to footer
Home
  • LinkedIn
  • Twitter

  • About Us
    • Overview
    • Executive Committee
    • Board Of Directors
  • Newsroom
    • Scientific Publications
    • Press Releases
    • Events
  • Partnering
  • Investors
    • Overview
    • Corporate Governance
    • Regulated Information
    • Shareholders Information
    • Shareholders Meeting
  • Contact Us

Half Year 2023 Financial Results and Business Update Conference Call (Sep 5)

August 30, 2023 Caroline Lonez

Conference call at 7 a.m. ET / 1 p.m. CET

The Company management will host a conference call on Tuesday, September 05 at 1 p.m. CET / 7 a.m. ET to discuss half year 2023 financial results and provide an update on the Company’s recent changes and upcoming milestones.

Participants may access the conference call either:

  • by dialing +1-877-407-9716 or +1-201-493-6779 (United States, International), +32 (0) 800-73-904  (Belgium Fixed) or +32 (0) 800-73-566 (Belgium Mobile). Please dial into the call five to ten minutes prior to start time using the appropriate number and ask to join the “Celyad Oncology SA call”
  • by clicking the “call me” link for instant telephone access to the event
  • or by connecting via live webcast link for instant webcast access to the event

Archived recording will be available on this website after the event.

Footer

Celyad Oncology

Celyad Oncology Logo
  • About
  • Newsroom
  • Partnering
  • Investors
  • Contact Us
  • LinkedIn
  • Twitter

Copyright © 2026 All Rights Reserved.

  • Cookie Policy |
  • Privacy Policy |
  • Terms of Use